Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations [NA]
Completed clinical trial aimed at creating a normal database for FDG-PET neurological examinations, sponsored by Central Hospital, Nancy, Fr…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors [Phase 2]
Phase 2 trial evaluates glutamine for vincristine-induced neuropathy in pediatric patients with lymphoma, leukemia, or solid tumors. The stu…
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan [Phase 2]
Phase 2 trial evaluating safety and efficacy of Nipent, Cytoxan, and Rituxan in lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)
The CARDIOTOX trial evaluating early assessment of anthracycline-induced cardiotoxicity has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma [Phase 2]
Phase 2 trial evaluating chemotherapy and rituximab with or without total-body irradiation and peripheral stem cell transplant in lymphoma; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies [Phase 1]
This Phase 1 clinical trial update reports on an anti-CD19 CAR-T cell therapy being tested in patients with B cell malignancies, including c…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Signal Detection in Monoclonal and New Agents in Lymphoma
The clinical trial NCT02849912 examining signal detection related to monoclonal antibodies and new agents in lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: A Phase II Study of Umbilical Cord Blood Transplantation [Phase 2]
A Phase II study of Umbilical Cord Blood Transplantation was terminated, with results posted in 2016 for diseases including leukemia, lympho…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma [Phase 2]
This Phase 2 trial evaluates conditioning with fludarabine and cyclophosphamide followed by peripheral stem cell transplant in patients with…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy [Phase 3]
A Phase 3 trial evaluating epoetin alfa for chemotherapy-induced anemia has completed, with an update summarizing trial status across multip…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated omega-3 fatty acids for advanced cancer patients with significant weight loss; the study has comp…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies [Phase 1]
Phase 1 study of idelalisib (IPI-145) in combination with Rituximab or Bendamustine/Rituximab in hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of sorafenib and everolimus in relapsed or refractory lymphoma and multiple myeloma with results po…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment [Phase 3]
Phase 3 trial evaluating ondansetron for chronic nausea and vomiting in patients with advanced cancer not caused by cancer treatment; the st…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment [Phase 1]
Phase 1 trial of the agent 506U78 in patients with hematologic cancers and kidney or liver impairment; the study has terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation for patients with relapsed hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer [NA]
This terminated clinical trial evaluated a conditioning regimen of fludarabine, cyclophosphamide, and total-body irradiation followed by cyc…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies [Phase 1]
Phase 1 safety study evaluating a natural killer (NK) cell line for hematologic cancers has completed, assessing its use against leukemia, l…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma [Phase 1]
This update reports the completion of a Phase 1 clinical trial evaluating SL-11047 in patients with relapsed or refractory lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy [Phase 4]
This is a Phase 4 clinical trial update for PEG-rhG-CSF in patients with lymphoma receiving chemotherapy. The study has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies [Phase 1]
Phase 1 trial evaluating a conditioning regimen of gemcitabine, busulfan, and melphalan with hematopoietic cell transplantation for advanced…
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: An Open Label Dose Escalation Study Of E7080 [Phase 1]
Open-label Phase 1 dose-escalation trial of E7080 (lenvatinib) in solid tumors and lymphomas completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: RTA 744 Injection in Patients With Leptomeningeal Disease [Phase 1]
Phase 1 trial of RTA 744 injection for leptomeningeal disease in patients with neoplastic meningitis and other CNS/solid tumors has been ter…
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Phase I Study of Sequential Cord Blood Transplants [Phase 1]
Phase I study of sequential cord blood transplants has completed enrollment for conditions including lymphoma, leukemia, multiple myeloma, a…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Korean Post-marketing Surveillance for Sprycel®
This is a completed Korean post-marketing surveillance study of Sprycel (dasatinib). It covered patients with chronic myelomonocytic leukemi…